BioCorRx raises $200K via note, warrant & inducement shares; note matures Sep 2024

BioCorRx Inc.

Issued $220K principal note (8% OID) for $200K cash; unsecured, matures Sep 8, 2024.
Six monthly amortization payments of $39,600 starting Apr 8, 2024; prepayable without penalty.
Issued 4-year warrant for 200K shares at $2.00/share exercise price.
Issued 24,000 restricted common shares as inducement.
Securities issued in private placement under Section 4(a)(2) to a single accredited investor.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.5

BioCorRx Inc. entered into Securities Purchase Agreement with an accredited investor valued at $200,000 (effective 2023-12-08).

Action: entry
Agreement: equity purchase
Counterparty: an accredited investor
Value: $200,000
Effective: 2023-12-08

Exact text from the filing

On December 8, 2023, BioCorRx Inc., a Nevada corporation (the “Company”), entered into a securities purchase agreement (the “SPA”) with an accredited investor (the “Investor”), whereby the Investor purchased from the Company, for a purchase price of $200,000 (the “Purchase Price”) (i) a promissory note of the Company in the original principal amount of $220,000.00 (the “Note”), (ii) a common stock purchase warrant for 200,000 shares (the “Warrant”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 24,000 restricted shares of Common Stock (the “Inducement Shares”, and collectively with the Note and Warrant, the “Securities”).

View on SEC.gov

Browse all material agreements →

BioCorRx Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-009154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.